Publications by authors named "Marco Antonio C Melo-Junior"
Article Synopsis
- Nitazoxanide was tested in a study to see its effects on COVID-19 patients, but it didn’t improve symptom resolution compared to a placebo.
- The trial involved 392 patients who received either nitazoxanide or a placebo, with findings showing a significant reduction in viral load for those on nitazoxanide.
- Overall, while nitazoxanide didn’t alleviate symptoms within 5 days, it was found to be safe and effective in lowering the amount of virus present in the body.
